SlideShare a Scribd company logo
NANOMEDICINE
    “ Tiny ” brings a plethora for
                  life


PREETHI SRIDHARAN
IV M.Sc. (BIOTECHNOLOGY)
ANNAMALAI UNIVERSITY
ANNAMALAI NAGAR
NANOMEDICINE
    The science and technology of diagnosing,
    treating and preventing disease and traumatic
    injury, of relieving pain and of preserving and
    improving human health, using molecular
    tools and molecular knowledge of the human
    body.
Applications of nanotechnology :
NANOTECHNOLOGY IN MEDICINE,
     WHAT FOR?
 SOLUBILITY ENHANCEMENT (NanoCrystal®
    Technology)
   BIOAVAILABILITY ENHANCEMENT
   DIAGNOSIS
    THERAPY
    TARGETING
                                        Doxil®
      -Passive targeting(Eg : Doxil®)
      -Active targeting(Eg: RONDEL™)
SOLUBILITY AND BIOAVAILABILITY
               ENHANCEMENT

 Up to 50% of existing drugs
 are insoluble

 Thus , bioavailability is
  very poor

 Micronization of
 insoluble drugs

 Wet-milling process

 Increased solubility
 and dissolution rate

 Enhanced Bioavailability
DIAGNOSIS

    Imaging
  technologies
  • MRI scanning
       • CT
  • PET scanning
LAB-ON-CHIP(LOC)
Magnetic resonance imaging (MRI)
 Uses a combination of a
  large magnet , radio
  frequencies and image
  reconstruction software to
  produce detailed images of
  organs and structures
      - Non-invasive
      - High resolution
      - No ionizing radiation
 Usually superparamagnetic
  particles are used
Advantages of NP-based MRI
       contrast agents
• Create image contrast enhancement
• Prolonged retention in circulation
• Tumor targeting
• May also carry anti-tumor agent (―Theragnostics‖)
 MRI of melanoma tumors before and after administration of
contrast agents
Preethi
Computed tomography (CT)
 Tomography is a ―splicing‖ of
    the
       body into various sections
    and planes
    Mainly used in the diagnosis of
    lung diseases(tuberculosis)
    Ionized NPs are instilled
    intrabronchially
    Contrast materials- NC70146
    (1-ethoxycarbonyl)((3,5-
    acetylamino)            -2,4,6-
    triiodobenzoate))-nanoparticle
    stabilized by surfactant
   Iodinized nanoparticles instilled
      into the small airways were
Positron Emission Tomography
    (PET)
 Diagnostic application that involves
    the acquisition of physiologic image
    based on the detection of radiation
    from the positron
    Positron emission tomography
    (PET) using 18F fluorodeoxyglucose
    (FDG) has been used successfully in
    the diagnosis of various cancers
           Advantages of NPs on PET
    Using nanoparticles with PET
    allows the quantitation of PET and
    the multifunctionality of
    nanoparticles to be taken advantage
    Deliver large number of imaging
    agents to molecular targets to
    achieve high sensitivity
    Different types of imaging agent to
    produce multimodality
Lab on chip (LOC)

 Lab on chip helps in
 disease diagnosis
Miniature Imaging Devices
 Imaging has developed a pill
  containing a miniature video
  system.
 When the pill is swallowed, it
  moves through the digestive
  system and takes pictures
  every few seconds.
 The entire digestive system
  can be assessed for tumors,
  bleeding, and diseases in
  areas not accessible with
  colonoscopies and endoscopies
 Nanoprobes (miniature
  machines) can attach
  themselves to particles in the
  body (e.g., antibodies) and
  emit a magnetic field.
Targeting

       Passive targeting
       Active targeting
PASSIVE TARGETING
 Passive targeting involves the
  preparation of drug carrier
  complex that can avoid elimination
  due to body defence mechanisms

 The complex will keep circulating in
  the blood stream and allow itself to
  be taken to the target receptor by
  some body property(pH,
  temperature etc)

 Nanoparticle systems exploit
  characteristics of tumor growth for
  the use of a passive form of
  targeting
ENHANCED PERMEABILITY AND
               RETENTION (EPR ) EFFECT

•   Various anatomical and
    functional abnormalities
    in tumor cells causes
    extravasation(“angiogene
    sis”), and other factors
    including poor lymphatic
    clearance cause retention
    of macromolecules – the
    phenomenon called EPR.

•   It is now the “Golden
    Mean” in anti-cancer
    drugs

•   Though of high
    significance with high
    MW drugs, this is not
    applicable to low MW
    ones for obvious reasons
FACTORS AFFECTING THE EPR EFFECT OF
     MACROMOLECULAR DRUGS IN SOLID TUMOR
 Active angiogenesis and high
    vascular density
    Extensive production of vascular
    mediators that facilitate
    extravasation, including
    Bradykinin
    nitric oxide
    VPF/VEGF
    prostaglandins
    collagenase (matrix
    metalloproteinase, MMP)
    Defective vascular architecture:
    for example, lack of smooth
    muscle layer cells, lack of or
    reduced receptors for angiotensin
    II, large gap in endothelial cell–
    cell junctions, anomalous
   conformation (branching or
    stretching etc.).
    Impaired lymphatic clearance of
    macromolecules and lipids from
 Polymer conjugates, in EPR
  context, have many upsides
  such as higher T1/2, better
  solubility, receptor mediated
  drug targeting and better
  quality of patient life

 While accelerated EPR can
  improve drug delivery and
  faster treatment, suppression
  of EPR is another approach,
  causing necrosis of tumor
  cells
ACTIVE TARGETING
•   On the horizon are nanoparticles that
     will actively target drugs to cancerous
     cells, based on the molecules that they
     express on their cell surface

• Active targeting or Ligand based
     targeting

• Specific biological processes such as
     Ligand-receptor recognition is used to
     accumulate the drug in the tumor cell

• Ligands /homing devices – antibodies,
     peptides, vitamins and sugars.
Two important qualities of an active targeting
          system
• Specificity of the
ligands onto the
receptors
• Capacity to
deliver the
required dose of
drug for required
period of time
SEM RESULTS
SHOWING THE
ENDOCYTOSIS OF NP
TARGETED ACTIVELY
SUSTAINED DRUG DELIVERY
   Controlled drug delivery is one which
    delivers the drug at a predetermined
    rate, for locally or systemically, for a
    specified period of time.

   Advantages
   Total dose is low.
    Reduced GI side effects.
    Reduced dosing frequency.
    Better patient acceptance and compliance.
    Less fluctuation at plasma drug levels.
    More uniform drug effect
    Improved efficacy/safety ratio
Nanorobots
 What are they?
 Nanorobots are
   nanodevices
 To repair or detect
   damages and infections.
 Exfuse themselves
“Athrough human excretory
    microscopic machine roaming
through the bloodstream, injecting
   system.
or taking samples for identification
and determining the concentrations
of different compounds"
Nanorobots –
   Features
 The powering of the
  nanorobots.
 Other sources of energy .
 Will be having onboard
  computers.
 Size of 0.5-3 micrometers.
 Carbon is the primary
  component.
 Self-replication
 They will be able to
  distinguish between different
  cell types by checking their
  surface antigens.               Virus detector
Nanorobots – functional
          requirements
 A navigational network has
    to be installed.

 This will enable the physician
    to keep track of the various
    devices in the body

    Nano-tracking may be able
    to detect tumors that are a
    few cells in size. (Alivisatos,
    2001)




A single inhaled nanorobot reaches, deeply
   inspired into the lungs and attaches to the
   tissue surface
DENTAL ROBOTS
 A mouthwash full of smart
  nanomachines could identify
  and destroy pathogenic
  bacteria while allowing the
  harmless flora of the mouth
  to flourish in a healthy
  ecosystem

Four remote-controlled nanorobots examine
  and clean the subocclusal surfaces of a
  patient's teeth, near the gumline.
 Emergency
 Management:

  The clottocyte
   concept
  Clot-inducing
   medical nanorobots
   with fully-deployed   CLOT-INDUCING MEDICAL
   netting capable of    NANOROBOTS ARE SHOWN IN
                         VARIOUS STAGES OF CLOT-NETTING
   embedding growing     DEPLOYMENT.
   clot with red cells
   and fibrin strands
CLOT-INDUCING MEDICAL              A REAL LIFE PICTURE OF
                                  ERYTHROCYTES TRAPPED
NANOROBOTS WITH FULLY-
                                  IN THE FIBRIN MESHWORK
DEPLOYED NETTING ARE SHOWN                OF A CLOT
EMBEDDED IN A PATCHLIKE GROWING
CLOT WITH RED CELLS AND FIBRIN
STRANDS INVOLVED (A CLOSER
The blue, octopus-like nanobot is one of billions of brain cell enhancers. The
central sphere houses a computer, with a storehouse of information equal to
many large libraries
Surgical Robotics

 Instead of manipulating surgical
  instruments, surgeons use their
  thumbs and fingers to move joystick
  handles on a control console to
  maneuver two robot arms containing
  miniature instruments that are
  inserted into ports in the patient. The
  surgeon’s movements transform large
  motions on the remote controls into
  micro-movements on the robot arms
  to greatly improve mechanical
  precision and safety
 A third robot arm holds a miniature
  camera, which is inserted through a
  small opening into the patient. The
  camera projects highly magnified 3-D
  images on a console to give a broad
  view of the interior surgical site.

  (The daVinci Surgical Robotics
  System)
Preethi
Nanoengineered Vaccines
 Engineer artificial / synthetic                                  NPs
  viruses
 Safe
                                                NP
 Less toxic than other adjuvants
 Cost-effective
 Enhance solubility/delivery of     Dendritic Cell (APC)                IFNg
                                                                                 IgG2a


  vaccine components
                                                                      B cell             IgG1, IgM,
 Co-delivery of antigen/adjuvant                   MHC II   Th2
                                                                                 IL-4
                                                                                         IgA, IgE


                               MHC I
 Improve cell uptake and
                                                                   IL-4, IL-5
                                                      CD4+         IL-6, IL-10
                                             Th1      T cell
                                 CD8+
  trafficking                    T cell             IL-2, IL-3,
                                                    IFNg, TNFa

 NP surface can be                                                 Humoral
                                                                   Responses
  functionalized                         Cellular
                                        Responses
 Cell-targeting
DiOC18 NPs in DC
Uptake of NPs BY DC




 Study performed at NIH/NIAID/VRC   ENTRY OF HIV INSIDE THE CEL
HIV Vaccine Concept
                                                                  A DC-targeted nanoparticle
                                                                   with conserved proteins Tat
                                                                      (1-72) and Gag p24 to
                                                                  generate protective Th1, CTL,
                                                                    and neutralizing antibody
          NIH-NIAID R01 AI058842                                     response s that may be
                                                                     further enhanced by co-
                                                                  delivery of Adjuvants (PRLs)

                        Dendritic Cell

                       Toll-like Receptor
                              (TLR-9)


           MHC I                        DC Mannose
                                         Receptor
                                                                                 Tat (1-72)

                                                                        PEG
                                                                                        Adjuvant
                                                     Mannopentaose
                                                       (DC targeting)                     (PRL)


                                                                              Gag p24

Tat & Gag p24 antigens: conserved; critical; CTLs detected in LTNPs
Achievement And Future
prospects for Nanomedicine:
    1st generation product (2000)
a)   Dispersed and contact nanostructure
     Ex-:colloids
b)   Product incorporating nanostructure
     Ex-:Polymer,nanostructured metal

    2nd active nanostructure (2000-2005)
a)   bio-active, health effect
     Ex-:targeted drugs,biodevices
b)   Physico chemical active adaptive structure
     Ex-:amplifier, actuators

    3rdNanosystem (2005-2010)
a)   Guided assembling
     Ex-:robotics, evolutionary biosystems

    4th Molecular nanosystems(2010-2020)
a)   Ex-: molecular devices ‘by design’
CONCLUSION
   The next BIG thing is really “small”

FUTURE NANO
Humanoid shaped
nanorobots




Respirocytes: Artificial RBC

More Related Content

PDF
20150924 smb noviocell juliette van den dolder
PPTX
Anticancer drug discovery using multicellular tumor spheroid models
PPT
Sk microfluidics and lab on-a-chip-ch3
PPTX
PROTEIN MICROARRAYS
PPTX
Genomics
PPTX
HAU SEMINAR 1 powerpoint - Copy
PPTX
1nanomedicine
20150924 smb noviocell juliette van den dolder
Anticancer drug discovery using multicellular tumor spheroid models
Sk microfluidics and lab on-a-chip-ch3
PROTEIN MICROARRAYS
Genomics
HAU SEMINAR 1 powerpoint - Copy
1nanomedicine

What's hot (20)

PPTX
Multiorgan microdevices
PPTX
Lab-on-a-Chip for cancer diagnostics and monitoring
PPTX
GENOMICS AND BIOINFORMATICS
PPTX
Micromanipulation
PPTX
Introduction to bionanomaterials
PPT
Sk microfluidics and lab on-a-chip-ch6
PPT
Sk microfluidics and lab on-a-chip-ch1
PPTX
Protein array, types and application
PDF
3D Cell Culture
PPTX
Synthetic cells
PPT
Bio-Nanotechnology
PPTX
The biolistic method
PPTX
Introduction to bionanomaterials
PDF
Building 3D Tissues for Transplantation and Drug Screening
PPTX
Prof. Mohamed Labib Salem's students
PPT
Genomics and bioinformatics
ODP
PDF
The Application of Nanotechnology to Regenerative Medicine
PPTX
Project.2020 ravera
PPTX
Computational Genomics - Bioinformatics - IK
Multiorgan microdevices
Lab-on-a-Chip for cancer diagnostics and monitoring
GENOMICS AND BIOINFORMATICS
Micromanipulation
Introduction to bionanomaterials
Sk microfluidics and lab on-a-chip-ch6
Sk microfluidics and lab on-a-chip-ch1
Protein array, types and application
3D Cell Culture
Synthetic cells
Bio-Nanotechnology
The biolistic method
Introduction to bionanomaterials
Building 3D Tissues for Transplantation and Drug Screening
Prof. Mohamed Labib Salem's students
Genomics and bioinformatics
The Application of Nanotechnology to Regenerative Medicine
Project.2020 ravera
Computational Genomics - Bioinformatics - IK
Ad

Viewers also liked (7)

PPT
Ich introduction
PPTX
Natural Polymers - Recent outcomes Vishnu Datta.M
PPT
Nanotechnology in pharmaceutics
PPTX
Co crystalization
PPT
Liquisolid technology
PPTX
Advances in tableitng technology
PPT
Solid lipid nanoparticle
Ich introduction
Natural Polymers - Recent outcomes Vishnu Datta.M
Nanotechnology in pharmaceutics
Co crystalization
Liquisolid technology
Advances in tableitng technology
Solid lipid nanoparticle
Ad

Similar to Preethi (20)

PPTX
Nano technology in medicine
PPTX
Nanotechnology in drug delivery final
PDF
applicationsofnanobiotechnologyinmedicine-200421050140.pdf
PPT
Applications of nanobiotechnology in medicine
PPTX
Unit 3c CELLULAR NEVIGATION.pptx
PPTX
NANOPARTICLES IN CANCER DIAGNOSIS AND TREATMENT
PPTX
1nanomedicine
PPTX
Masserini erice
PPT
nanotechnology in drug delivery and diagnostic
PPT
Nano technology and its releavance to drug designing 08072013
PPTX
Nano Enabled Drug Delivery (NEDD)
PPTX
Nanoparticles in diagnostics and therapy
PPTX
Nanotechnoloy in Cancer.pptx
PDF
PDF
Nanomedicine the future
PPTX
Use of nanotechnology in medical science (pros and cons)
PPTX
Nanotechnology to detect cancer
PPTX
Nanotechnology
PPTX
Nanomedicine
PPTX
Nanomedicine current status and future prospects
Nano technology in medicine
Nanotechnology in drug delivery final
applicationsofnanobiotechnologyinmedicine-200421050140.pdf
Applications of nanobiotechnology in medicine
Unit 3c CELLULAR NEVIGATION.pptx
NANOPARTICLES IN CANCER DIAGNOSIS AND TREATMENT
1nanomedicine
Masserini erice
nanotechnology in drug delivery and diagnostic
Nano technology and its releavance to drug designing 08072013
Nano Enabled Drug Delivery (NEDD)
Nanoparticles in diagnostics and therapy
Nanotechnoloy in Cancer.pptx
Nanomedicine the future
Use of nanotechnology in medical science (pros and cons)
Nanotechnology to detect cancer
Nanotechnology
Nanomedicine
Nanomedicine current status and future prospects

Recently uploaded (20)

PPTX
Belch_12e_PPT_Ch18_Accessible_university.pptx
DOCX
unit 2 cost accounting- Tender and Quotation & Reconciliation Statement
PDF
20250805_A. Stotz All Weather Strategy - Performance review July 2025.pdf
PDF
Dr. Enrique Segura Ense Group - A Self-Made Entrepreneur And Executive
PDF
A Brief Introduction About Julia Allison
DOCX
unit 1 COST ACCOUNTING AND COST SHEET
PPTX
CkgxkgxydkydyldylydlydyldlyddolydyoyyU2.pptx
PPTX
AI-assistance in Knowledge Collection and Curation supporting Safe and Sustai...
PDF
Nidhal Samdaie CV - International Business Consultant
PPTX
Amazon (Business Studies) management studies
PDF
COST SHEET- Tender and Quotation unit 2.pdf
PPTX
Business Ethics - An introduction and its overview.pptx
PDF
Deliverable file - Regulatory guideline analysis.pdf
PDF
MSPs in 10 Words - Created by US MSP Network
PDF
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
PDF
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
PDF
Laughter Yoga Basic Learning Workshop Manual
PDF
Elevate Cleaning Efficiency Using Tallfly Hair Remover Roller Factory Expertise
DOCX
Business Management - unit 1 and 2
PDF
pdfcoffee.com-opt-b1plus-sb-answers.pdfvi
Belch_12e_PPT_Ch18_Accessible_university.pptx
unit 2 cost accounting- Tender and Quotation & Reconciliation Statement
20250805_A. Stotz All Weather Strategy - Performance review July 2025.pdf
Dr. Enrique Segura Ense Group - A Self-Made Entrepreneur And Executive
A Brief Introduction About Julia Allison
unit 1 COST ACCOUNTING AND COST SHEET
CkgxkgxydkydyldylydlydyldlyddolydyoyyU2.pptx
AI-assistance in Knowledge Collection and Curation supporting Safe and Sustai...
Nidhal Samdaie CV - International Business Consultant
Amazon (Business Studies) management studies
COST SHEET- Tender and Quotation unit 2.pdf
Business Ethics - An introduction and its overview.pptx
Deliverable file - Regulatory guideline analysis.pdf
MSPs in 10 Words - Created by US MSP Network
BsN 7th Sem Course GridNNNNNNNN CCN.pdf
kom-180-proposal-for-a-directive-amending-directive-2014-45-eu-and-directive-...
Laughter Yoga Basic Learning Workshop Manual
Elevate Cleaning Efficiency Using Tallfly Hair Remover Roller Factory Expertise
Business Management - unit 1 and 2
pdfcoffee.com-opt-b1plus-sb-answers.pdfvi

Preethi

  • 1. NANOMEDICINE “ Tiny ” brings a plethora for life PREETHI SRIDHARAN IV M.Sc. (BIOTECHNOLOGY) ANNAMALAI UNIVERSITY ANNAMALAI NAGAR
  • 2. NANOMEDICINE  The science and technology of diagnosing, treating and preventing disease and traumatic injury, of relieving pain and of preserving and improving human health, using molecular tools and molecular knowledge of the human body.
  • 4. NANOTECHNOLOGY IN MEDICINE, WHAT FOR?  SOLUBILITY ENHANCEMENT (NanoCrystal® Technology)  BIOAVAILABILITY ENHANCEMENT  DIAGNOSIS  THERAPY  TARGETING Doxil® -Passive targeting(Eg : Doxil®) -Active targeting(Eg: RONDEL™)
  • 5. SOLUBILITY AND BIOAVAILABILITY ENHANCEMENT  Up to 50% of existing drugs are insoluble  Thus , bioavailability is very poor  Micronization of insoluble drugs  Wet-milling process  Increased solubility and dissolution rate  Enhanced Bioavailability
  • 6. DIAGNOSIS Imaging technologies • MRI scanning • CT • PET scanning LAB-ON-CHIP(LOC)
  • 7. Magnetic resonance imaging (MRI)  Uses a combination of a large magnet , radio frequencies and image reconstruction software to produce detailed images of organs and structures - Non-invasive - High resolution - No ionizing radiation  Usually superparamagnetic particles are used
  • 8. Advantages of NP-based MRI contrast agents • Create image contrast enhancement • Prolonged retention in circulation • Tumor targeting • May also carry anti-tumor agent (―Theragnostics‖) MRI of melanoma tumors before and after administration of contrast agents
  • 10. Computed tomography (CT)  Tomography is a ―splicing‖ of the body into various sections and planes  Mainly used in the diagnosis of lung diseases(tuberculosis)  Ionized NPs are instilled intrabronchially  Contrast materials- NC70146 (1-ethoxycarbonyl)((3,5- acetylamino) -2,4,6- triiodobenzoate))-nanoparticle stabilized by surfactant  Iodinized nanoparticles instilled into the small airways were
  • 11. Positron Emission Tomography (PET)  Diagnostic application that involves the acquisition of physiologic image based on the detection of radiation from the positron  Positron emission tomography (PET) using 18F fluorodeoxyglucose (FDG) has been used successfully in the diagnosis of various cancers Advantages of NPs on PET  Using nanoparticles with PET allows the quantitation of PET and the multifunctionality of nanoparticles to be taken advantage  Deliver large number of imaging agents to molecular targets to achieve high sensitivity  Different types of imaging agent to produce multimodality
  • 12. Lab on chip (LOC)  Lab on chip helps in disease diagnosis
  • 13. Miniature Imaging Devices  Imaging has developed a pill containing a miniature video system.  When the pill is swallowed, it moves through the digestive system and takes pictures every few seconds.  The entire digestive system can be assessed for tumors, bleeding, and diseases in areas not accessible with colonoscopies and endoscopies  Nanoprobes (miniature machines) can attach themselves to particles in the body (e.g., antibodies) and emit a magnetic field.
  • 14. Targeting Passive targeting Active targeting
  • 15. PASSIVE TARGETING  Passive targeting involves the preparation of drug carrier complex that can avoid elimination due to body defence mechanisms  The complex will keep circulating in the blood stream and allow itself to be taken to the target receptor by some body property(pH, temperature etc)  Nanoparticle systems exploit characteristics of tumor growth for the use of a passive form of targeting
  • 16. ENHANCED PERMEABILITY AND RETENTION (EPR ) EFFECT • Various anatomical and functional abnormalities in tumor cells causes extravasation(“angiogene sis”), and other factors including poor lymphatic clearance cause retention of macromolecules – the phenomenon called EPR. • It is now the “Golden Mean” in anti-cancer drugs • Though of high significance with high MW drugs, this is not applicable to low MW ones for obvious reasons
  • 17. FACTORS AFFECTING THE EPR EFFECT OF MACROMOLECULAR DRUGS IN SOLID TUMOR  Active angiogenesis and high vascular density  Extensive production of vascular mediators that facilitate extravasation, including  Bradykinin  nitric oxide  VPF/VEGF  prostaglandins  collagenase (matrix metalloproteinase, MMP) Defective vascular architecture:  for example, lack of smooth muscle layer cells, lack of or reduced receptors for angiotensin II, large gap in endothelial cell– cell junctions, anomalous  conformation (branching or stretching etc.).  Impaired lymphatic clearance of macromolecules and lipids from
  • 18.  Polymer conjugates, in EPR context, have many upsides such as higher T1/2, better solubility, receptor mediated drug targeting and better quality of patient life  While accelerated EPR can improve drug delivery and faster treatment, suppression of EPR is another approach, causing necrosis of tumor cells
  • 19. ACTIVE TARGETING • On the horizon are nanoparticles that will actively target drugs to cancerous cells, based on the molecules that they express on their cell surface • Active targeting or Ligand based targeting • Specific biological processes such as Ligand-receptor recognition is used to accumulate the drug in the tumor cell • Ligands /homing devices – antibodies, peptides, vitamins and sugars.
  • 20. Two important qualities of an active targeting system • Specificity of the ligands onto the receptors • Capacity to deliver the required dose of drug for required period of time SEM RESULTS SHOWING THE ENDOCYTOSIS OF NP TARGETED ACTIVELY
  • 21. SUSTAINED DRUG DELIVERY  Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time.  Advantages  Total dose is low.  Reduced GI side effects.  Reduced dosing frequency.  Better patient acceptance and compliance.  Less fluctuation at plasma drug levels.  More uniform drug effect  Improved efficacy/safety ratio
  • 22. Nanorobots  What are they?  Nanorobots are nanodevices  To repair or detect damages and infections.  Exfuse themselves “Athrough human excretory microscopic machine roaming through the bloodstream, injecting system. or taking samples for identification and determining the concentrations of different compounds"
  • 23. Nanorobots – Features  The powering of the nanorobots.  Other sources of energy .  Will be having onboard computers.  Size of 0.5-3 micrometers.  Carbon is the primary component.  Self-replication  They will be able to distinguish between different cell types by checking their surface antigens. Virus detector
  • 24. Nanorobots – functional requirements  A navigational network has to be installed.  This will enable the physician to keep track of the various devices in the body  Nano-tracking may be able to detect tumors that are a few cells in size. (Alivisatos, 2001) A single inhaled nanorobot reaches, deeply inspired into the lungs and attaches to the tissue surface
  • 25. DENTAL ROBOTS  A mouthwash full of smart nanomachines could identify and destroy pathogenic bacteria while allowing the harmless flora of the mouth to flourish in a healthy ecosystem Four remote-controlled nanorobots examine and clean the subocclusal surfaces of a patient's teeth, near the gumline.
  • 26.  Emergency Management:  The clottocyte concept  Clot-inducing medical nanorobots with fully-deployed CLOT-INDUCING MEDICAL netting capable of NANOROBOTS ARE SHOWN IN VARIOUS STAGES OF CLOT-NETTING embedding growing DEPLOYMENT. clot with red cells and fibrin strands
  • 27. CLOT-INDUCING MEDICAL A REAL LIFE PICTURE OF ERYTHROCYTES TRAPPED NANOROBOTS WITH FULLY- IN THE FIBRIN MESHWORK DEPLOYED NETTING ARE SHOWN OF A CLOT EMBEDDED IN A PATCHLIKE GROWING CLOT WITH RED CELLS AND FIBRIN STRANDS INVOLVED (A CLOSER
  • 28. The blue, octopus-like nanobot is one of billions of brain cell enhancers. The central sphere houses a computer, with a storehouse of information equal to many large libraries
  • 29. Surgical Robotics  Instead of manipulating surgical instruments, surgeons use their thumbs and fingers to move joystick handles on a control console to maneuver two robot arms containing miniature instruments that are inserted into ports in the patient. The surgeon’s movements transform large motions on the remote controls into micro-movements on the robot arms to greatly improve mechanical precision and safety  A third robot arm holds a miniature camera, which is inserted through a small opening into the patient. The camera projects highly magnified 3-D images on a console to give a broad view of the interior surgical site. (The daVinci Surgical Robotics System)
  • 31. Nanoengineered Vaccines  Engineer artificial / synthetic NPs viruses  Safe NP  Less toxic than other adjuvants  Cost-effective  Enhance solubility/delivery of Dendritic Cell (APC) IFNg IgG2a vaccine components B cell IgG1, IgM,  Co-delivery of antigen/adjuvant MHC II Th2 IL-4 IgA, IgE MHC I  Improve cell uptake and IL-4, IL-5 CD4+ IL-6, IL-10 Th1 T cell CD8+ trafficking T cell IL-2, IL-3, IFNg, TNFa  NP surface can be Humoral Responses functionalized Cellular Responses  Cell-targeting
  • 32. DiOC18 NPs in DC Uptake of NPs BY DC Study performed at NIH/NIAID/VRC ENTRY OF HIV INSIDE THE CEL
  • 33. HIV Vaccine Concept  A DC-targeted nanoparticle with conserved proteins Tat (1-72) and Gag p24 to generate protective Th1, CTL, and neutralizing antibody NIH-NIAID R01 AI058842 response s that may be further enhanced by co- delivery of Adjuvants (PRLs) Dendritic Cell Toll-like Receptor (TLR-9) MHC I DC Mannose Receptor Tat (1-72) PEG Adjuvant Mannopentaose (DC targeting) (PRL) Gag p24 Tat & Gag p24 antigens: conserved; critical; CTLs detected in LTNPs
  • 34. Achievement And Future prospects for Nanomedicine:  1st generation product (2000) a) Dispersed and contact nanostructure Ex-:colloids b) Product incorporating nanostructure Ex-:Polymer,nanostructured metal  2nd active nanostructure (2000-2005) a) bio-active, health effect Ex-:targeted drugs,biodevices b) Physico chemical active adaptive structure Ex-:amplifier, actuators  3rdNanosystem (2005-2010) a) Guided assembling Ex-:robotics, evolutionary biosystems  4th Molecular nanosystems(2010-2020) a) Ex-: molecular devices ‘by design’
  • 35. CONCLUSION  The next BIG thing is really “small” FUTURE NANO Humanoid shaped nanorobots Respirocytes: Artificial RBC